Course and outcome for schizophrenia versus other psychotic patients: a longitudinal study

Schizophrenia Bulletin
M HarrowJ F Goldberg

Abstract

We studied 276 patients longitudinally, beginning at the acute phase and continuing at three successive followups over 7.5 years, comparing 74 schizophrenia patients with 74 other psychotic patients and 128 nonpsychotic patients on early course and outcome. Schizophrenia patients showed significantly poorer functioning than patients with other psychotic disorders at each of the three followups (p < 0.05). More schizophrenia patients than other psychotic patients showed consistent psychopathology and a course in which there was not complete remission at any of the three followups (p < 0.05). Most schizophrenia patients did not show severe decrements in social activity level. Poor outcome schizophrenia patients showed significantly slower recovery at each followup than did other psychotic patients with initial poor outcomes (p < 0.01). The results indicate that, during the early course, schizophrenia patients still show relatively poor outcomes, although a small number of schizophrenia patients enter into complete remission. Over time, many schizophrenia patients fluctuate between severe disability and moderate disability rather than always showing severe disability. Schizophrenia patients tend to recover more slowly then other p...Continue Reading

Citations

Jul 25, 2009·Social Psychiatry and Psychiatric Epidemiology·Malin AleniusLeif Lindström
Oct 22, 2010·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Alvin H H WongMichael G C Yiu
Oct 28, 1999·Biological Psychiatry·R J WyattJ J Bartko
Sep 25, 2003·Comprehensive Psychiatry·Martin HarrowThomas H Jobe
Feb 27, 2004·Schizophrenia Research·Edward I GelberRaquel E Gur
Sep 16, 2009·Psychological Medicine·C González-BlanchB Crespo-Facorro
Aug 14, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Adrienne C LahtiKaren L Cropsey
Feb 5, 2008·Schizophrenia Bulletin·Nancy M DochertyJames P Seghers
Dec 20, 2008·Schizophrenia Bulletin·Gregory P StraussCherise Rosen
Nov 7, 2009·Schizophrenia Bulletin·Nancy M DochertyMarielle Divilbiss
Oct 11, 2012·International Journal of Mental Health Systems·Maria Cristina TurolaChiara Scapoli
Jan 2, 2004·The British Journal of Psychiatry : the Journal of Mental Science·Mirella RuggeriPaola Ognibene
Sep 11, 2010·Schizophrenia Research·Syed ShamsiAnil K Malhotra
Apr 21, 2009·Comprehensive Psychiatry·Jonas EberhardEva Lindström
Dec 19, 2007·Journal of Psychiatric Research·Malin AleniusMargareta Hammarlund-Udenaes
Oct 28, 2010·Early Intervention in Psychiatry·Cindy P-Y ChiuEric Y-H Chen
Oct 6, 1999·Biological Psychiatry·E J Bromet, S Fennig
Mar 15, 2006·European Psychiatry : the Journal of the Association of European Psychiatrists·Barbara LayWulf Rössler
Apr 10, 2003·The Psychiatric Clinics of North America·Mary Clarke, Eadbhard O'Callaghan
Jan 1, 1999·International Journal of Psychiatry in Clinical Practice·V LernerI Polyakova
Jan 14, 2004·The Journal of Nervous and Mental Disease·Martin HarrowKalman J Kaplan
Oct 30, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jennifer A HadleyAdrienne C Lahti
Apr 15, 2006·The Journal of Nervous and Mental Disease·Katherine E BurdickAnil K Malhotra
Oct 7, 2017·The British Journal of Psychiatry : the Journal of Mental Science·John LallyRobin M Murray
Nov 4, 2000·The British Journal of Psychiatry : the Journal of Mental Science·M HarrowE W Davies
Feb 7, 2001·The British Journal of Psychiatry : the Journal of Mental Science·S P SinghG Harrison
Jan 1, 2009·The International Journal of Neuroscience·Toshimi OwashiKunitoshi Kamijima
May 29, 1999·The Journal of Nervous and Mental Disease·J M RacensteinR Schleser
Nov 19, 2002·The Journal of Nervous and Mental Disease·Robyn A ReedEileen M Martin
Jul 21, 2020·Stress : the International Journal on the Biology of Stress·Preethi PremkumarJoshua Baker
Feb 24, 2006·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Jennifer PayneBrown Nicole
Feb 24, 2006·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Thomas H Jobe, Martin Harrow
Feb 24, 2006·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Martin Harrow, Thomas H Jobe

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.